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West Virginia Medical Center, Morgantown, West Virginia 26506 
Three  antibodies  reacting with corneal  keratan sul- 
fate proteoglycan were used to detect antigenically 
related  molecules  in 11 bovine  and 13 embryonic  chick 
tissues. Two monoclonal  antibodies  recognized  sulfated 
epitopes on the  keratan  sulfate  chain  and  a  polyclonal 
antibody  bound  antigenic sites on the  core  protein of 
corneal  keratan sulfate proteoglycan.  Competitive  im- 
munoassay  detected  core  protein  and  keratan  sulfate 
antigens in guanidine HC1 extracts of most tissues. 
Keratan sulfate antigens of  most bovine tissues were 
only  partially extracted with guanidine HC1, but the 
remainder  could  be  solubilized  by CNBr treatment  of 
the  guanidine-extracted  residue.  Keratan  sulfate  and 
core  protein antigens co-eluted with purified  corneal 
keratan sulfate proteoglycan on ion exchange high- 
performance  liquid  chromatography  (HPLC).  Endo-8- 
galactosidase  digestion  of  the  HPLC-purified  keratan 
sulfate antigens  eliminated  the  binding  of  monoclonal 
anti-keratan sulfate antibodies in enzyme-linked  im- 
munosorbent assay. Extracts of all 11 bovine  tissues, 
except  those  from  brain  and cartilage, could  bind  both 
anti-keratan sulfate monoclonal antibodies and anti- 
core  protein  polyclonal  antibody  simultaneously.  Bind- 
ing was sensitive to competition with keratan sulfate 
and  to  digestion with endo-@-galactosidase.  These re- 
sults suggest  widespread  occurrence  of  a  proteoglycan 
or sulfated  glycoprotein  bearing  keratan sulfate-like 
carbohydrate and a core protein resembling that of 
corneal  keratan sulfate proteoglycan. 
Keratan sulfate is  a  linear polymer of N-acetyllactosamine 
(Galpl-4GlcNAc) dissacharides joined by Dl-3 linkage (lac- 
tosaminoglycan). Keratan  sulfate is sulfated at  the C-6 posi- 
tions of both glucosamine and galactose moieties. Proteogly- 
cans bearing keratan  sulfate  chains have been characterized 
in  three different tissues: cornea, cartilage, and  brain (1, 2). 
In each of the  three tissues, the core proteins of the proteo- 
glycans are  distinct, with keratan  sulfate  attached to  the core 
by different linkage oligosaccharides. Corneal keratan  sulfate 
is attached to core protein through an N-linked branched 
mannose-containing oligosaccharide that  is identical to  that 
found in complex-type oligosaccharides of neutral glycopro- 
teins.  Keratan  sulfate from cartilage is linked to serine by an 
0-glycosidic bond through galactosamine (1) and brain kera- 
tan sulfate is 0-linked to serine  through mannose (2). The 
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term  keratan sulfate, therefore, describes a diverse group of 
polysaccharides which share  the same sulfated poly-N-acetyl- 
lactosamine structure. 
The presence of keratan sulfate-containing proteoglycans 
as major components of the extracellular matrix of the cornea 
and of cartilage has been known for some time (1). More 
recently keratan sulfate has been identified in brain (2), in 
the  skin of several marine fish (3, 4), in bone (5), in masto- 
cytoma tumor  (6), and  in teratocarcinoma cells (7). Smaller 
sulfated oligosaccharides structurally related to keratan  sul- 
fate have been found in lymphocytes and virus-infected chick 
embryos (8,9). Lactosaminoglycan, a nonsulfated analogue of 
keratan sulfate, has been reported in cell membrane glycopro- 
teins of several cell types (10-12), in mucins from the gas- 
trointestinal tract  and ovarian cysts (13, 14), and  in extracel- 
lular  matrix covalently linked to fibronectin (15). These re- 
ports suggest that distribution of keratan sulfate-containing 
proteoglycans and glycoproteins may be more widespread 
than originally thought. 
During the last 5 years several antibodies have been isolated 
to keratan sulfate and to core proteins of keratan sulfate- 
containing proteoglycans (16-23). These antibodies appear 
highly specific (24,25)  and have provided sensitive detection 
of keratan sulfate by immunohistochemistry in cultured chon- 
drocytes (19, 26, 27) and in developing cornea and skeletal 
tissues (21, 28-30). Immunoassay using anti-keratan sulfate 
antibodies has been  used to  quantitate  keratan sulfate anti- 
gens in  human  serum (31) and in extracts of developing chick 
cornea (30). 
In  this study we used three previously characterized anti- 
bodies with reported activities against  keratan sulfate proteo- 
glycans to survey bovine and embryonic chick tissues for the 
presence of antigens  related to keratan  sulfate  and to corneal 
KSPG’ core protein. We find that compounds antigenically 
related to corneal KSPG can be detected in all tissues. 
EXPERIMENTAL  PROCEDURES 
Materials 
Purification of monoclonal antibodies I22 against rabbit corneal 
keratan sulfate (16), and 5-D-4 against bovine cartilage keratan 
sulfate (17) was described previously. Each of these antibodies rec- 
ognizes sulfated epitopes on the keratan sulfate chains from both 
or linkage carbohydrate (16, 17). Polyclonal rabbit  antiserum against 
cartilage and corneal keratan  sulfate but  not epitopes in the protein 
bovine KSPG (18) was further purified by affinity for immobilized 
bovine corneal KSPG (30). Purified bovine corneal keratan sulfate 
was obtained from Miles Laboratories. The preparation of bovine 
KSPG, desulfated bovine corneal keratan sulfate, whale cartilage 
The abbreviations used are: KSPG, corneal keratan  sulfate pro- 
teoglycan; ELISA, enzyme-linked immunosorbent assay; PBS, 10 mM 
sodium phosphate, 0.15 M NaCl, 0.01% (w/v) thimerosal, pH 7.4; 
HPLC, high-performance liquid chromatography. 
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keratan sulfate  (18), and of rabbit corneal keratan sulfate (16), were 
described previously, as was purification of endo-@-galactosidase from 
Escherichia freundii (32). Bovine corneal KSPG was deglycosylated 
3 h at  0 "C, with trifluoromethane-sulfonic acid as described (33). 
The free core protein was recovered by ion exchange HPLC as 
described below. The deglycosylated core did not adhere to the column 
and was detected by protein assay and by ELISA with the polyclonal 
antibody. 
Tissue Extraction 
Tissues  (fresh  or frozen at -70 "C) were freed of connective tissue 
and  fat, minced, and extracted twice, 24 h each, a t  4 "C, in  10 volumes 
(w/v) 4 M guanidine HCl, containing protease inhibitors (0.1 M 6- 
aminohexanoic acid, 5 mM benzamidine, 1 mM phenylmethylsulfonyl 
fluoride, 10 mM EDTA, 10 mM N-ethylmaleimide), 0.05 M acetate 
buffer, pH 6.0, and 1% Triton X-100. Solutions were cleared by 
centrifugation at  l0,OOO X g for 10 min. Pooled guanidine HCl extracts 
were dialyzed at 4 "C against 6 M deionized urea in 20 mM Tris-HC1, 
pH 6.8 with the same protease inhibitors as above, then filtered 
through a glass fiber filter and stored at  4 "C. Protein  content of the 
extract was determined with the Bio-Rad protein assay (34). Tissue 
remaining  after guanidine HC1 extraction was rinsed  free of guanidine 
HCI in distilled water (4-6 changes), a t  4 'C then dried in a vacuum 
centrifuge. Residue from 0.5 g of wet weight tissue was resuspended 
in 5 ml of 70% formic acid, containing 100 mg of CNBr and incubated 
capped at 25 "C overnight, vortexing occasionally. Addition of 100 
mg of CNBr and a second overnight incubation was usually per- 
formed. CBNr was removed by repeated evaporation to dryness from 
70% formic acid at  reduced pressure. For quantitative immunoassay 
the dry residue was resupended  in 70% formic acid and dialyzed 
against 17 mM acetic acid in the cold. For ion exchange chromatog- 
raphy the dried residue was resuspended directly in 6 M urea with 20 
mM Tris sulfate, pH 6.8. Insoluble residue was removed by centrif- 
ugation at  10,OOO X g, 10 min. 
I m m u w s a y s  
All ELISA procedures were carried out at 25 "C, with 2-3 PBS 
rinses between incubations, and dilutions were made in 1% (w/v) 
bovine serum albumin, 0.1% (v/v) Tween 20 detergent  in PBS (block- 
ing buffer), except as noted. 
Competitiue EUSA-Competitive ELISA using a biotin-labeled 
purified corneal KSPG standard was described previously (30). Com- 
petitive assays with polyclonal antibody used biotin-labeled corneal 
KSPG, affinity-purified on  antibody 122-agarose as described previ- 
ously for '%I-KSPG (16). 
Direct ELISA-Direct ELISA was carried out by coating a poly- 
styrene ELISA plate (Nunc 439454, Vanguard International, Nep- 
tune,  NJ) with 50 pl of 0.07% glutaraldehyde freshly made in 0.1 M 
phosphate, pH 5.0, for 30 min. Samples diluted to 50 pl in 6 M urea 
were incubated in  the wells overnight, and additional binding was 
blocked by incubation with blocking buffer for 1 h. Anti-KSPG 
antibody  in 50 pl was added for 2 h (overnight for antibody I22 assay 
of column fractions) followed by incubation with peroxidase-labeled 
goat anti-moue  or  anti-rabbit IgG F(ab), (TAGO, Burlingame, CA) 
for 1 h. Color was developed with 3,3',5,5'-tetramethylbenzidine as 
described (35) for 10 min. 
Double  Antibody ELZSA-Double antibody ELISA was carried out 
by adsorption of monoclonal I22 or 5-D-4 to ELISA plates overnight 
a t  4 "C in 0.1 M NaHC03 buffer, pH 9. After blocking, primary 
incubation was carried out for 2 h with tissue extracts diluted in 
blocking buffer. Inhibition by keratan sulfate was assessed by addition 
of 1 mg/ml bovine corneal keratan  sulfate  during the primary incu- 
bation. Sensitivity of the bound antigen to endo-&galactosidase was 
assessed after primary incubation, by incubation with endo-D-galac- 
tosidase for 30 min at  37 'C as described below, omitting urea in  the 
buffer. Binding of polyclonal antibody to the antigen-monoclonal 
antibody complex was assessed by a 2-h incubation with the diluted 
antibody followed by reaction with peroxidase-labeled goat anti- 
rabbit IgG F(ab), and color development as described above. 
Ion Exchange HPLC 
One-half-ml aliquots of the filtered tissue  extracts  in 6 M urea were 
injected on a 1-ml Pharmacia Mono Q anion exchange HPLC column. 
Elution was carried out in 6 M urea, 20 mM Tris sulfate, pH 6.8, using 
a gradient of increasing slope from 0-1.5 M Na2S0, a t  a flow rate of 
1 ml per min at  room temperature. Fractions of  0.3 ml were collected 
and assayed for protein and for KSPG  antigens by direct ELISA as 
described above. 
Endo-&galactosidase Treatment 
PoolecLpeak fractions from ion exchange columns (fractions 60- 
80) were dialyzed against 6 M urea, 20 mM Tris-sulfate, pH 6.8, and 
KSPG standards were dissolved in the same solution. E. freundii 
endo-@-galactosidase was added to a final concentration of 0.025 
units/ml, sodium acetate, pH 5.8, was added to 0.2 M, and four 
protease inhibitors (16)  were  added. Digestion was conducted for 2 h 
a t  room temperature. Dilutions of digests were bound onto a glutar- 
aldehyde-treated ELISA plate and assayed with 5-D-4, 122, or poly- 
clonal antibodies in  direct  ELISA as described above. 
RESULTS 
Comparison of Anti-keratan Sulfate Antibodies-Three pre- 
viously described antibodies made to different keratan  sulfate- 
containing proteoglycans (16-18) were compared using whole 
and  partially degraded bovine corneal KSPG. In direct 
ELISA, the two monoclonal antibodies bound to whole KSPG, 
but only weakly to endo-8-galactosidase-treated KSPG. No 
binding was detected to chemically deglycosylated KSPG 
protein core (Fig. 1, A and B) .  This activity is consistent with 
the previously determined specificity of the monoclonal an- 
tibodies for epitopes localized in  keratan  sulfate glycosami- 
noglycan chains  and  not for epitopes in core protein or linkage 
r" , 4 
t 10 100 1 om 
1 10 100 1 OO( 
KSPG (ng) 
FIG. 1. Direct ELISA of corneal KSPG components. Bovine 
KSPG (solid circles), endo-8-galactosidase-treated KSPG (open cir- 
cles), and deglycosylated KSPG core protein (squares and broken line) 
were assayed for their ability to bind each of three antibodies by 
ELISA as described under "Experimental Procedures." Error  bars 
show f l  S.D. and are  omitted if the  standard deviation was less than 
the diameter of the symbol. A, antibody 122; B, antibody 5-D-4; C, 
polyclonal antibody. 
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region of the keratan  sulfate (16, 17). In contrast, a polyclonal 
antibody to purified bovine corneal KSPG (M), affinity- 
purified on KSPG-agarose (30), bound KSPG and endo-& 
galactosidase-treated KSPG equally well (Fig. IC). Binding 
to deglycosylated KSPG core was somewhat reduced com- 
pared to whole proteoglycan (Fig. IC). The affinity-purified 
polyclonal antibody, therefore, appears to recognize antigens 
on  the core protein of KSPG. 
In  the competitive assay, keratan sulfate preparations from 
several sources varied in ability to bind the monoclonals. As 
shown in Table I, purified keratan sulfate glycosaminoglycan 
preparations were weaker competitors than  KSPG  and also 
differed in  their competitive abilities according to  the source 
of the  keratan sulfate. The weakest binding to both  antibodies 
was from chemically desulfated keratan sulfate, confirming 
the requirement for sulfation of the binding site recognized 
by the monoclonal antibodies. The monoclonal antibodies 
also differed from each other in relative response to each 
keratan sulfate preparation, suggesting that these two anti- 
bodies may recognize slightly different sulfated epitopes in 
the keratan sulfate chain. MonoclonaI antibodies had no 
response to heparin  or  other glycosaminoglycans, nor did the 
polyclonal antibody bind purified keratan sulfate or other 
glycosaminoglycans in  this assay (not shown). 
Keratan Sulfate Antigens in Tissue Extracts-KSPG-re- 
lated  antigens recognized by the  three antibodies were meas- 
ured in  extracts of several bovine and embryonic chick tissues. 
As shown in  Table 11, antigens competing with corneal KSPG 
were detected in most of the bovine tissues examined. Anti- 
gens competing for binding of the affinity-purified polyclonal 
antibody were most widespread and abundant, whereas mono- 
clonal 5-D-4 was the most restrictive in identifying KSPG- 
related antigens. The amount of antigen varied widely among 
tissues: cornea > cartilage >> tissues  containing muscle (skel- 
etal  and cardiac muscle, lung, and  intestine). Fibrous tissue 
(skin and bovine sclera) were very low in keratan sulfate 
antigens  but rich in core protein  antigens recognized  by the 
polyclonal antibody. Liver consistently contained the least 
KSPG antigens. In a similar survey of 13 tissues from 20-day 
embryonic chick, keratan  sulfate  antigens were found in all 
except liver and skin, with abundance  distribution similar to 
that of bovine tissues (not shown). The tissues surveyed were: 
aorta, bone, brain, cartilage, cornea, gizzard, intestine, liver, 
lung, skeletal muscle, cardiac muscle, sclera, and  skin. 
In many bovine tissues, part of the KSPG  antigens were 
not  extracted by guanidine HC1, but could be solubilized by 
treatment of the previously guanidine HC1-extracted tissue 
with CNBr. The guanidine HC1-resistant antigen was most 
abundant  in  striated muscle tissues, where it comprised the 
majority of the  total keratan  sulfate  antigen (99% in bovine 
TABLE I 
Comparison of keratan sulfate antigens with anti-keratan sulfate 
morwcbnal antibodies by competitiue ELISA 
Values show the amount of each type of keratan sulfate ( p g  of 
galactose) reouired to reduce the binding of a biotin-labeled bovine 
corneal KSPG standard to 50% of uninhibited levels. Amounts were 
normalized to KSPG = 1 for comparison of the two antibodies. 
Keratan sulfate 
trpe 
Relative competitive 
abilities 
I22 5-D-4 
~~ 
KSPG, bovine cornea  1 1 
Keratan sulfate, bovine cornea 5.3  11.4
Keratan sulfate, rabbit cornea 1.4 5.5 
Keratan sulfate, whale cartilage 252 51 
Desulfated keratan sulfate, >loo0 930 
"~ 
bovine cornea 
cardiac muscle (Table 11)). Significant amounts of guanidine 
HC1-resistant KSPG  antigens were also found in bovine and 
chick cornea and  in bovine lung, kidney, and skin. The CNBr- 
solubilized antigens were typically more reactive with anti- 
body 5-D-4 than with 122, indicating possible differences in 
the structure of keratan sulfate antigens in this fraction 
(Table 11). 
Double  Antibody  Binding-The data in Table I1 show  wide 
distribution of antigens from both carbohydrate and  protein 
components of corneal KSPG. Table I11 demonstrates the 
physical association of these two antigens in the tissue ex- 
tracts by assessing the ability of the antigens to bind  both 
anti-keratan sulfate monoclonal and polyclonal antibodies 
simultaneously. As seen in  Table 111, color development was 
dependent on incubation with both monoclonal and polyclo- 
nal antibodies. Competition with keratan  sulfate glycosami- 
noglycan blocked >90% of the color development resulting 
from incubation with guanidine HCl extracts  and blocked 40- 
50% of the color developed  by CNBr-extracted  antigens from 
muscle and skin. Treatment of the  keratan sulfate antigen- 
antibody complex with endo-&galactosidase, resulted in a 20- 
50% reduction of color development. These controls demon- 
strate specificity of the monoclonal antibody for legitimate 
keratan  sulfate  antigens in this assay. Of bovine tissues listed 
in Table 11, all but cartilage (shown) and  brain  (not shown) 
had antigens responding in this assay. Poor response from 
antigens  in  these two tissues would  be expected because in 
these two tissues keratan sulfate is linked to core proteins 
different from corneal KSPG core protein. Monoclonal anti- 
body 5-D-4 also participated  in double antibody binding in a 
similar manner  (not shown). 
Ion Exchange HPLC of the Tissue Extracts-Fig. 2 com- 
pares elution patterns of guanidine HC1 extracts of bovine 
cornea and kidney tissue on anion exchange HPLC. In each 
case, more than 95% of the protein in the sample was eluted 
by 0.1 M sulfate. Keratan sulfate antigens, detected by ELISA, 
eluted between 0.35-1.5 M sulfate in a single broad peak (Fig. 
2, A and B) .  Similar elution profiles were obtained from 
purified bovine corneal KSPG,  as well as from guanidine HC1 
extracts of all the bovine tissues listed in Table I1 (except 
from liver, which had no detectable activity). Assay with the 
affinity-purified polyclonal antibody found KSPG core pro- 
tein-related  antigen  in fractions of the gradient overlapping 
the peak of keratan  sulfate  antigen in extracts of cornea (Fig. 
2C), kidney (Fig. 2D), and  all  other tissues examined in  Table 
I1 (data  not shown). For several tissues (brain, liver, cardiac 
and skeletal muscle, intestine, and kidney) core protein anti- 
gen  was found only in  the high ionic strength  elutate (e.g. Fig. 
ZO), but some tissues (cornea, lung, skin, cartilage, and sclera) 
also contained related antigens  eluting earlier in the gradient 
(as  in Fig.  2C). 
Chromatography of CNBr-solubilized antigens of bovine 
cornea  and cardiac muscle is shown in Fig. 3. Keratan  sulfate 
antigens  reacting with antibody 122, from these two samples 
(Fig. 3, A and B) ,  eluted in a similar manner to  keratan sulfate 
antigens from the guanidine HCl extract shown in Fig. 2. 
Antigenic components reacting with the polyclonal antibody 
(Fig. 3, C and D) were found in low ionic strength  eluate  and 
also in a typically broad peak co-eluting with the keratan 
sulfate antigens. CNBr digests of bovine skeletal muscle, skin, 
kidney, and lung were also chromatographed with similar 
results (not shown). 
Sensitivity of Keratan Sulfate Antigen to Endo-/I-galuctosid- 
me-Fig. 4 shows endo-&galactosidase sensitivity of antigens 
in pooled HPLC peak fractions of corneal guanidine HC1 
extracts (Fig. 2 A )  and cardiac muscle CNBr extracts (Fig. 
Keratan Sulfate-related Proteoglycans 
TABLE I1 
Quantitative estimate of KSPG antigens in guanidine HCl extracts and CNBr digests of bovine tissues 
KSPG antigens were measured in  extracts  and  digests of tissues using the competitive  ELISA, as described 
under “Experimental  Procedures.”  Values  shown  indicate the weight of bovine  corneal  KSPG  containing  the  same 
amount  of  antigen as the experimental  sample.  Repeatability  of  the  assay  was  typically from 50 to 200% of the 
values  shown. Sensitivity of the assay was equivalent to -1 pg  of KSPG/g  of tissue (122, polyclonal)  and -0.1 pg 
of KSPGk of tissue (5-D-4). 
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Tissue 
Brain 
Cartilage 
Cornea 
Muscle (skeletal) 
Muscle  (cardiac) 
Intestine 
Kidney  cortex 
Kidney  medulla 
Liver 
Lung 
Sclera 
Skin 
Antibody 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polyclonal 
I22 
5-D-4 
Polvclonal 
Amount  of antigen 
Guanidine HCI CNBr Total 
Guanidine HCI CNBr 
g KSPG/g tissue 
” 
% Total 
10 
0 
43 
1195 
196 
1653 
3019 
3722 
8154 
9 
0 
1386 
1 
0 
249 
10 
0 
2000 
28 
55 
28 
0 
333 
0 
0 
0 
22 
41 
3 
1 
734 
3 
0 
1541 
0.1 
0.1 
3B). Reactivity in  direct ELISA with both monoclonal anti- 
bodies was eliminated by endo-@-galactosidase treatment of 
the  keratan sulfate  antigens from both corneal and cardiac 
muscle extracts (Fig. 4, A-D). Similar endo-@-galactosidase 
sensitivity was found for chromatographically purified kera- 
tan sulfate antigen from all other tissues with sufficient 
antigen for assay (guanidine HC1 extracts from cartilage, 
kidney, lung, and skin; CNBr  extracts from skeletal muscle). 
Binding of the polyclonal antibody to purified KSPG  anti- 
gens in guanidine HC1 extracts from cornea (Fig. 4E), as well 
as other tissues (not shown), was not affected by endo-@- 
galactosidase treatment. Endo-@-galactosidase treatment of 
pooled peak fractions of CNBr digests from muscle (Fig. 4F),  
and  other  CNBr digests, reduced but did not  eliminate poly- 
clonal antibody binding. This  pattern of sensitivity demon- 
0 
0 
0 
0 
7 
5 
943 
1124 
122 
144 
22 
144 
91 
9 
57 
0 
0 
6 
6 
0 
15 
5 
0 
11 
0 
0 
8 
3 
23 
0.2 
0 
0 
27 
3 
0 
10 
0 
43 
1195 
203 
1658 
3962 
4846 
8276 
153 
22 
1530 
92 
9 
306 
10 
0 
2006 
34 
70 
33 
0 
344 
0 
0 
8 
25 
64 
3 
1 
761 
6 
0 
0.1 
0.3 
100 
100 
100 
97 
100 
76 
77 
99 
6 
0 
91 
1 
0 
81 
100 
100 
82 
78 
85 
97 
0 
88 
33 
64 
100 
100 
96 
50 
0 
0 
0 
3 
0 
24 
23 
1 
94 
100 
9 
99 
100 
19 
0 
0 
18 
22 
15 
3 
100 
12 
67 
36 
0 
0 
4 
50 
25 1566 98 2 
strates  that endo-D-galactosidase digests the keratan sulfate 
antigen  without blocking reactivity of protein antigens in the 
same fractions. 
DISCUSSION 
The  data presented here demonstrate that proteoglycans 
with antigenic and physical properties similar to corneal 
KSPG  can be extracted from many body tissues. The abun- 
dance and extractability of these proteoglycans vary with 
respect to  the tissue. We hypothesize t h d  these antigens may 
be a family of proteoglycans related to corneal KSPG. 
All of the tissues listed in Table I1 reacted with the  anti- 
keratan sulfate monoclonal antibodies in the competitive 
assay (Table 11) or  in one of the direct ELISA tests  (Table 
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TABLE I11 
Double antibody binding by tissue  extracts 
Tissue extracts and digests were assayed for simultaneous binding 1.5 
of polyclonal and monoclonal antibody I22 by double antibody ELISA 
as described under “Experimental Procedures.” Values are averages 1 I. o 
of four replicate data points. Values for the “complete” assay are 
significantly (p < 0.025) greater than all other conditions for each + o. 
assay (except for cartilage). Abbreviations: Muscle (S), skeletal mus- 
Cor ne a Muscle 
cle. Kidney (C), kidney cortex. Q) 
Conditions of assay s o  j 2.0 
p” 1.0 
Tissue Plus Endo-8- Minus Minus 
plete keratan galacto- mono- poly- sulfate sidase clonal clonal 
absorbance x450 nm 
& 
0 
4 
Guanidine HC1 
extracts 0 
Cornea 0.894 0.060  0.692  - 0185 0 20 40 80 80 0 20 SO 80  80
Muscle (S) 0.872 -0.016 0.559 -0.001 0.095 
Kidney (C) 0.195 0.019 0.107 0.002 -0.026 
Liver 0.186 0.058 0.112 -0.003 -0.030 
Cartilage 0.007 0.079 0.063 0.020 0.105 
CNBr digests 
Cornea 0.149 -0.027 0.042 -0.023 0.002 
Muscle (S) 0.176 0.108 0.084 -0.008 0.016 
Skin 0.342 0.168 0.261 -0.011 -0.017 
Cornea Kidnev 
0 
1.0 7 
v 
0.5 
rn 
0’ 
Fr ac t  ion Number 
FIG. 2. Ion exchange HPLC of guanidine €IC1 tissue ex- 
tracts. HPLC of the unfractionated extracts of bovine cornea ( A  and 
C )  and kidney (E  and D )  was carried out in 6 M urea, 20 mM Tris- 
SO,, with a 0-1.5 M gradient of Na2SOI as described under “Experi- 
mental Procedures.” Solid circles show direct ELISA with monoclonal 
antibody I22 ( A  and B )  and with polyclonal antibody (C and D). 
Dotted line (C and D )  shows concentration of eluting  Na2S04. Dashed 
lines ( A  and B )  show protein  concentration  in mg/ml. Bar in C shows 
fractions pooled for endo-@-galactosidase digestion in Fig. 4. 
111, Figs. 2 and 3). The recent  literature  contains an increasing 
number of reports of compounds related to  keratan sulfate in 
tissues  other than cartilage and cornea. However, this study 
appears to be the  first  to suggest that some keratan  sulfate 
may be present in virtually all tissues. This discovery was 
made possible by the monoclonal antibodies against  keratan 
sulfate. Previous characterization of these antibodies showed 
that they bind sulfated regions of keratan sulfate, but not 
other glycosaminoglycans, or related sulfated glycoproteins 
such as mucins (17, 18, 24). Recent studies with monoclonal 
5-D-4 found that  this antibody does not recognize  fully sul- 
fated  keratan  sulfate  fragments  shorter  than hexasaccharides, 
nor are nonsulfated keratan sulfate fragments bound (24,25). 
This requirement for more than two repeated sulfated lac- 
tosamine disaccharides insures that  the antigens detected by 
this antibody are sulfated large oligo- or polysaccharides 
Fraction Number 
FIG. 3. Ion exchange HPLC of  CNBr extracts. CNBr digests 
of bovine cornea (A and C) and of cardiac muscle ( B  and D) were 
fractionated by HPLC as described under “Experimental Proce- 
dures.” Data  are displayed as in Fig. 2. The absorbance scale in D is 
0.4 X scale values of C.  Bar in D shows fractions pooled for endo-8- 
galactosidase digestion in Fig. 4. 
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FIG. 4. Effect of  endo-&galactosidase on KSPG antigens  in 
collected column fractions. Fractions 60-80 pooled from the chro- 
matograms shown in Figs. 2C and 3 0  were treated with endo-8- 
galactosidase in  the presence of protease inhibitors as described under 
“Experimental Procedures.” Direct ELISA of the treated (broken 
lines) and untreated (solid lines) antigens was compared for corneal 
guanidine HCl extract (A, C, and E )  and for cardiac muscle CNBr 
digest (B, D, and F) with three antibodies: I22 ( A  and B); 5-D-4 (C 
and D);  polyclonal ( E  and F).  Error bars are shown as Fig. 1. 
rather  than nonsulfated lactosaminoglycans or short sulfated 
lactosamine-containing oligosaccharides, such as  those of 
lymphocytes and virus-infected chicken embryos (8,9). 
Even though the monoclonal antibodies react with a well- 
defined component of keratan sulfate, the possibility exists 
that  the structures recognized in tissue extracts  are unknown 
keratan sulfate-like carbohydrates different from the keratan 
sulfate of cornea and cartilage. Sensitivity of the tissue  anti- 
gens to endo-@-galactosidase, therefore, provides independent 
confirmation of the poly-N-acetyllactosamine carbohydrate 
composition of these antigens. Endo-@-galactosidase is a well- 
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characterized and highly specific enzyme requiring a mini- 
mum structure of glcNAc~(1-3)gal~(1-4)glcNAC (32). Degra- 
dation of the antigenic material with endo-8-galactosidase 
demonstrates the presence of legitimate keratan  sulfate which 
was inferred from the antibody reactivity. Together, monoclo- 
nal antibody reactivity and endo-8-galactosidase sensitivity 
leave little question that  the tissue  antigens described here 
contain oligosaccharide regions identical to the polymeric 
keratan  sulfate of cornea and cartilage. On the basis of the 
current data, no conclusions can be drawn about the possible 
presence of branched  chains, the chain  length,  or the  nature 
of the protein-keratan  sulfate linkage regions. These analyses 
must await detailed structural studies on purified tissue 
KSPG antigens. 
The polyclonal antibody provided specificity to a com- 
pletely different portion of the KSPG molecule than that 
recognized  by the monoclonal antibodies. Although the  un- 
fractionated antiserum does bind  keratan  sulfate  (18),  it  is 
clear from Fig. 1, that  after affinity purification, no reactivity 
with free keratan  sulfate remains. Reaction with deglycosy- 
lated  KSPG core (Fig. IC) suggests that  the polyclonal pri- 
marily recognizes the polypeptide sequence, and  not the neu- 
tral oligosaccharides, of the KSPG core protein. Further  char- 
acterization of this  antiserum2 found >90% of the reactivity 
of purified KSPG was in endo-8-galactosidase-sensitive ma- 
terial.  Thus,  antigens recognized  by this antibody are  keratan 
sulfate-linked proteins, not unrelated proteins which may 
have contaminated the  KSPG originally used as immunogen. 
Competitive assay with the polyclonal antibody was carried 
out  against  a labeled KSPG  standard which had been purified 
by adsorption to immobilized antibody 122. This procedure 
further insured that  the antigens detected in tissue extracts 
were related to keratan sulfate-linked protein of corneal 
KSPG  and  not  to  contaminating proteins. 
Antigens from two separate components of corneal KSPG 
(keratan  sulfate  and core protein) were found widely distrib- 
uted, with a generally similar abundance  (Table 11). A portion 
of the two antigens co-chromatographs on HPLC ion ex- 
change (Figs. 2 and 3). This circumstantial evidence for 
presence of these  antigens in the same molecule  was corrob- 
orated by the demonstration  (Table 111) of a physical associ- 
ation of the two antigens. Specificity of this double antibody 
binding for keratan  sulfate was shown by sensitivity to com- 
petition with purified keratan sulfate and by sensitivity to 
endo-8-galactosidase treatment of the antibody-antigen com- 
plex. An important  control regarding specificity of the poly- 
clonal antibody in this experiment was the nonreactivity of 
brain  and cartilage extracts,  both of which contain  keratan 
sulfate linked to a  protein core differing from that of cornea 
(1, 2). These  data suggest that  the  keratan sulfate in many 
non-corneal tissues  is part of a proteoglycan containing pro- 
tein and keratan sulfate antigenic sites related to those of 
corneal KSPG. The existence of families of proteoglycans 
ranging over many tissues, containing similar or identical core 
proteins, has recently been reported by Heinegard and co- 
workers (36). The antigens detected in our study may repre- 
sent  a previously undetected family of proteoglycans related 
to corneal KSPG. 
It is apparent from Table I1 that  the proteins recognized  by 
the polyclonal antibody were relatively more abundant  than 
the keratan  sulfate  antigens in tissues  other than cornea and 
cartilage. This was most evident in fibrous tissues, such as 
sclera and skin. These data suggest the presence of core 
protein antigens with little or no sulfated keratan sulfate. 
J. L. Funderburgh, B. Caterson, and G. W. Conrad, unpublished 
observations. 
HPLC profiles of cornea (Fig. 2C), as well as  those of skin 
and sclera (not shown), indeed contain much material reacting 
with polyclonal antibody that elutes at lower ionic strength 
than does keratan sulfate. This  material might be unrelated 
protein containing antigenic sites in common with KSPG 
core protein. On the  other hand, these  data could be explained 
by the presence, in  skin, sclera, and  other tissues, of a  KSPG- 
like proteoglycan that has relatively low sulfation. Its low 
sulfation would result  in  little  or no reaction with anti-keratan 
sulfate monoclonal antibodies and in elution at a low ionic 
strength from the HPLC. A low ionic charge would confer 
physical properties different from those of highly sulfated 
proteoglycans, thus explaining why such a compound has  not 
been previously described. 
An interesting observation of the current work is that from 
some tissues  KSPG  antigens were marginally soluble in 4 M 
guanidine HCl. Insolubility of a portion of corneal KSPG 
(37), cartilage proteoglycan (38), and basement membrane 
proteoglycans (39) in guanidine HCl has been reported pre- 
viously. The resistance of much collagen to extraction with 
guanidine HCl and  its ready solubilization with CNBr sug- 
gests an association of guanidine HC1-resistant KSPG with 
collagen. Recent ultrastructural  studies found corneal KSPG 
associated with regions of corneal collagen fibrils correspond- 
ing to  the ends of collagen  molecules (40). This association of 
KSPG with a specific portion of the corneal collagen mole- 
cules and its resistance to extraction with guanidine HCl 
suggest a possible covalent collagen-KSPG link. Recent find- 
ings of covalent linkages between chondroitin sulfate and 
collagen (41) and between heparan sulfate and fibronectin 
(15) lend credibility to  this possibility. 
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